Christopher Quarles

Title: The Innovative Contributions of Christopher Quarles

Introduction

Christopher Quarles is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of medical imaging, particularly in the area of MRI technology. His work focuses on improving the measurement of tumor hemodynamic parameters, which is crucial for cancer diagnosis and treatment.

Latest Patents

Quarles holds a patent for an innovative MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation. This method involves acquiring one or two sets of time course NMR data using an EPI pulse sequence. The process includes the acquisition of gradient recalled echo NMR signals and spin-echo NMR signals after the bolus injection of a contrast agent. T* relaxation rates for gradient echo and T relaxation rates for spin-echo are calculated from the acquired NMR signals and corrected for the extravasation of the contrast agent into surrounding tissues. The resulting hemodynamic parameter maps serve as a measure of tumor angiogenesis, providing valuable insights for medical professionals.

Career Highlights

Christopher Quarles is associated with the MCW Research Foundation, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the field of oncology by enhancing the understanding of tumor behavior and treatment responses.

Collaborations

Quarles has collaborated with esteemed colleagues, including Kathleen M. Schmainda and B. Douglas Ward. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in medical research.

Conclusion

Christopher Quarles is a pioneering inventor whose contributions to MRI technology are making a difference in cancer diagnostics. His innovative methods and collaborative efforts are paving the way for advancements in medical imaging and patient care.